In primary colon cancers, methylation of the MLH1 promoter region is a subset of MSI. MLH1 inactivation in an early stage of primary CRC has been shown to be an important biomarker in advanced diseases, thus having a good prognostic value [87]. This evidence concerns the gene MLH1 and colonic neoplasm.